Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

2,738

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

2,738 results for “Multiple Sclerosis”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

ClinicalTrials.gov study NCT00134563. IPD Sharing: Not stated. Countries: 21. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx

ClinicalTrials.gov study NCT00211887. IPD Sharing: Not stated. Countries: 2. Publications: 12.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Short-term B-cell Depletion in Relapsing Multiple Sclerosis

ClinicalTrials.gov study NCT03853746. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Stem Cells in Rapidly Evolving Active Multiple Sclerosis

ClinicalTrials.gov study NCT01606215. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of a Spasticity Management Program for People With Multiple Sclerosis

ClinicalTrials.gov study NCT03166930. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

ClinicalTrials.gov study NCT02342704. IPD Sharing: Not stated. Countries: 9. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

ClinicalTrials.gov study NCT00836719. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

ClinicalTrials.gov study NCT02977533. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)

ClinicalTrials.gov study NCT00950248. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

ClinicalTrials.gov study NCT03562975. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment

ClinicalTrials.gov study NCT01285401. IPD Sharing: Not stated. Countries: 12. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

ClinicalTrials.gov study NCT04544436. IPD Sharing: YES. Countries: 21. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis

ClinicalTrials.gov study NCT02047734. IPD Sharing: Not stated. Countries: 21. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series

ClinicalTrials.gov study NCT02335450. IPD Sharing: YES. Countries: 1. Publications: 12.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Cognitive Rehabilitation for People With Multiple Sclerosis

ClinicalTrials.gov study NCT06179134. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a

ClinicalTrials.gov study NCT01514370. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the Reb

ClinicalTrials.gov study NCT01791244. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis

ClinicalTrials.gov study NCT00997438. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.

ClinicalTrials.gov study NCT04877457. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Tele-Exercise and Multiple Sclerosis

ClinicalTrials.gov study NCT03117881. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record